Skip to Main Content


Skip Nav Destination


2024 Corecipients

photo of Yong Du, PhD

Yong Du, PhD
Director, Jing Medicine Technology (Shanghai) Co., Ltd.

🙘    🙚

photo of Tracy T. Tang, PhD

George Zhang, PhD
CEO, Akeylink Biotechnology

Read the article:

HJM-561, a Potent, Selective, and Orally Bioavailable EGFR PROTAC that Overcomes Osimertinib-Resistant EGFR Triple Mutations
Molecular Cancer Therapeutics
July 2022.

Molecular Cancer Therapeutics Award for Outstanding Journal Article

The Molecular Cancer Therapeutics Award for Outstanding Journal Article is awarded to the corresponding author of a peer-reviewed, original Research Article published within the previous two years that has made significant and timely contributions to one or more of the areas represented by the Journal.

Award Criteria:

The Editor-in-Chief and two additional editors for the Journal will select the Award recipient each year, in consideration of the following criteria:

  • Editors will prioritize those articles that have the potential to shift paradigms, inspire translational activity, and raise awareness of new scientific areas.
  • Editors will prioritize articles that are representative of the Journal in terms of originality/novelty, scientific/clinical merit, and/or impact/significance.

The Award:

The Award recipient will be invited to the Journals Reception and the President’s Reception that take place during the AACR Annual Meeting. A cash prize of $1,500 and a certificate will be given to the awardee.

Past Recipient

2023: Tracy T. Tang


Close Modal

or Create an Account

Close Modal
Close Modal